Outpatient, short-term, once-daily, diluted, 0.1% mometasone furoate wet-wraps for childhood atopic eczema

Journal of Dermatological Treatment

Volumn 10, Issue 3, 1999, Pages 157-163

  Tang, William Y M ^a,c   Chan, H H L ^b   Lam, V M F ^a   Chong, L Y ^d   Lo, K K ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Department of Community Medicine   (Hong Kong)

^d NONE

Author keywords

0.1 mometasone furoate; Atopic eczema; Wet wraps

Indexed keywords

EMOLLIENT AGENT; HYDROCORTISONE; MOMETASONE FUROATE; STEROID;

ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; FEMALE; FOLLICULITIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; PRURITUS; SCORING SYSTEM; SYMPTOM; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0032837856     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639909056022     Document Type: Article

References (16)

1. Nicol NH, Atopic dermatitis: the (wet) wrap-up. Am J Nurs (1987) 12: 1560-3.
2. Harper J, Topical corticosteroids for skin disorders in infants and children. Drugs (1988) 36 (Suppl 5): 34-7.
3. Goodyear HM, Spowart K, Harper JL, "Wet-wrap" dressings for the treatment of atopic eczema in children. Br J Dermatol (1991) 125: 604 (letter).
4. Mallon E, Powell S, Bridgman A, "Wet-wrap" dressings for the treatment of atopic eczema in the community. J Dermatol Treat (1994) 5: 97-8.
5. Bridgman A, The use of wet wrap dressings for eczema. Paediatr Nurs (1995) 7: 24-7.
6. Prakash A, Benfield P, Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. Drugs (1988) 55: 145-63.
7. European Task Force on Atopic Dermatitis, Consensus Report, Severity scoring of atopic dermatitis: the SCORAD index. Dermatology (1993) 186: 23-31.
8. Taylor B, Wadsworth J, Wadsworth M, Peckham C, Changes in the reported prevalence of childhood eczema since the 1938-45 war. Lancet (1984) 2 (8414): 1255-7.
9. Larson FS, Holm NV, Henningsen K, Atopic dermatitis. A genetic-epidemiological study in a population-based twin sample. J Am Acad Dermatol (1986) 15: 487-94.
10. Eaton KK, The incidence of allergy - has it changed? Clin Allergy (1979) 9: 53-60.
11. Neame RL, Berth-Jones J, Kurinczuk JJ, Graham-Brown RA, Prevalence of atopic dermatitis in Leicester: a study of methodology and examination of possible ethnic variation. Br J Dermatol (1995) 132: 772-7.
12. Bridgman A, Management of atopic eczema in the community. Health Visit (1994) 67: 226-7.
13. Berth-Jones J, Finlay AY, Zaki J et al, Cyclosporine in severe atopic dermatitis: a multicenter study. J Am Acad Dermatol (1996) 34: 1016-21.
14. Vernon HJ, Lane AT, Weston W, Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. J Am Acad Dermatol (1991) 24: 603-7.
15. Wilkinson SM, Beck MH, Fluticasone propionate and mometasone furoate have a low risk of contact sensitization. Contact Dermatitis (1996) 34: 365-6.
16. Kerscher MJ, Hart H, Korting HC, Stalleicken D, In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new. Int J Clin Pharmacol Ther (1995) 33: 187-9.